2-202513893-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001204.7(BMPR2):c.529+64C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,290,226 control chromosomes in the GnomAD database, including 11,421 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1185 hom., cov: 32)
Exomes 𝑓: 0.13 ( 10236 hom. )
Consequence
BMPR2
NM_001204.7 intron
NM_001204.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.50
Publications
3 publications found
Genes affected
BMPR2 (HGNC:1078): (bone morphogenetic protein receptor type 2) This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, May 2020]
BMPR2 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-202513893-C-T is Benign according to our data. Variant chr2-202513893-C-T is described in ClinVar as [Benign]. Clinvar id is 1281801.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18050AN: 151674Hom.: 1182 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18050
AN:
151674
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.129 AC: 146636AN: 1138432Hom.: 10236 AF XY: 0.129 AC XY: 74512AN XY: 579616 show subpopulations
GnomAD4 exome
AF:
AC:
146636
AN:
1138432
Hom.:
AF XY:
AC XY:
74512
AN XY:
579616
show subpopulations
African (AFR)
AF:
AC:
2290
AN:
26464
American (AMR)
AF:
AC:
6313
AN:
40472
Ashkenazi Jewish (ASJ)
AF:
AC:
1492
AN:
23592
East Asian (EAS)
AF:
AC:
84
AN:
37874
South Asian (SAS)
AF:
AC:
9886
AN:
76306
European-Finnish (FIN)
AF:
AC:
9098
AN:
50822
Middle Eastern (MID)
AF:
AC:
350
AN:
3904
European-Non Finnish (NFE)
AF:
AC:
111174
AN:
829448
Other (OTH)
AF:
AC:
5949
AN:
49550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6067
12133
18200
24266
30333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.119 AC: 18067AN: 151794Hom.: 1185 Cov.: 32 AF XY: 0.120 AC XY: 8937AN XY: 74168 show subpopulations
GnomAD4 genome
AF:
AC:
18067
AN:
151794
Hom.:
Cov.:
32
AF XY:
AC XY:
8937
AN XY:
74168
show subpopulations
African (AFR)
AF:
AC:
3731
AN:
41392
American (AMR)
AF:
AC:
2073
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
240
AN:
3462
East Asian (EAS)
AF:
AC:
21
AN:
5156
South Asian (SAS)
AF:
AC:
554
AN:
4812
European-Finnish (FIN)
AF:
AC:
1974
AN:
10482
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9197
AN:
67946
Other (OTH)
AF:
AC:
188
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
791
1581
2372
3162
3953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
157
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.